-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Because the development difficulty and cost of the first generic drug are much lower than that of the innovative drug, the efficacy of the product has been verified, and the market has been opened and paved by the original drug, so it has always been the focus of pharmaceutical compani.
In recent years, the first generic drug in China has become one of the key areas of competition for pharmaceutical companies to expand their territo.
In this context, more and more first generic drugs have begun to emer.
For example, recently, more than 2 pharmaceutical companies have their first generic drugs approved and listed on the same d.
Kelun Pharmaceuticals Gadoteridol Injection was approved for marketing on May 27 On the same day, NMPA issued an approval document showing that Kelun Pharmaceutical's "Gadoterol Injection" was approved for marketing, which was deemed to have passed the consistency evaluation and became the first domestic imitati.
Gadoteridol injection is a magnetic resonance contrast agent developed by Italian Brac.
It has been approved for marketing in the United States, Japan, Europe and other countri.
It was approved for import in China in 201 It is used for magnetic resonance imaging of brain, spine and surrounding tissue lesio.
Enhanced scan and whole-body M.
According to the Insight database, apart from Kelun Pharmaceuticals, no other domestic company has developed gadoterol injecti.
According to reports, gadoterol injection is the third approved product of Kelun Pharmaceutical in the field of diagnostic imaging after iopamidol injection and disodium gadoxetate injecti.
The declared gadobutrol injection and the series of X-ray, magnetic resonance and ultrasound contrast agents under development together form a cluster of advantageous products in the field of diagnostic contra.
It is worth mentioning that in recent years, Kelun Pharmaceutical has achieved a lot in terms of first generic drugs through innovati.
On April 29 this year, Kelun Pharmaceuticals issued an announcement that Sildenafil Citrate Orally Disintegrating Tablets was approved, which is also the first imitation in Chi.
According to the data, sildenafil is the first phosphodiesterase type 5 selective inhibitor approved in the world for the treatment of erectile dysfuncti.
first-line medicati.
In 2020, China's public hospitals and retail pharmacies sold a total of 66 billion yu.
Hengrui Medicine Diquafosol Sodium Eye Drops Approved for Marketing On May 27, NMPA issued an approval document showing that Hengrui Medicine's "Diquafosol Sodium Eye Drops" was approved for marketing, which is deemed to have passed the consistency evaluation and became the The first imitation in Chi.
Diquafosol sodium is a P2Y2 receptor agonist, which acts on P2Y2 receptors on the conjunctival epithelium and goblet cell membrane, and improves dry eye disease by up-regulating intracellular calcium ion concentration and promoting the secretion of water and muc.
sympto.
The drug was developed by Santen Pharmaceutical under license from Inspire Pharmaceuticals (a subsidiary of Merck) and was approved in Japan for the treatment of dry eye in October 201 It was approved for import in China in October 2017, and the trade name is Liai.
At present, in addition to Hengrui, five other companies have also applied for diquafosol sodium eye drops, including Qilu Pharmaceutical, Yangzijiang Pharmaceutical, and Xingqi Eye Dro.
It is understood that since the beginning of this year, Hengrui Medicine has approved a number of first generic drugs for marketi.
For example, on January 20, the three types of generic drug "Nimodipine Oral Solution" submitted by Hengrui Medicine were approved for marketi.
At present, the approved dosage forms of nimodipine in China include ordinary tablets, capsules, and injectio.
This time, Hengrui Medicine's nimodipine oral solution has been reviewed and won the first domestic imitation + first review of this varie.
Conclusion In fact, the first generic drugs have always been one of the focuses of domestic pharmaceutical companies' R&D layout, especially with the continuous advancement of the drug review reform, such drugs are becoming a sharp weapon for market competiti.
The industry expects that more and more generic drugs will be launched in the future, and with the approval of more generic drugs and new drugs under research, the competition in the domestic pharmaceutical market will become more intense, and the pace of domestic substitution will also be further speed .
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.
In recent years, the first generic drug in China has become one of the key areas of competition for pharmaceutical companies to expand their territo.
In this context, more and more first generic drugs have begun to emer.
For example, recently, more than 2 pharmaceutical companies have their first generic drugs approved and listed on the same d.
Kelun Pharmaceuticals Gadoteridol Injection was approved for marketing on May 27 On the same day, NMPA issued an approval document showing that Kelun Pharmaceutical's "Gadoterol Injection" was approved for marketing, which was deemed to have passed the consistency evaluation and became the first domestic imitati.
Gadoteridol injection is a magnetic resonance contrast agent developed by Italian Brac.
It has been approved for marketing in the United States, Japan, Europe and other countri.
It was approved for import in China in 201 It is used for magnetic resonance imaging of brain, spine and surrounding tissue lesio.
Enhanced scan and whole-body M.
According to the Insight database, apart from Kelun Pharmaceuticals, no other domestic company has developed gadoterol injecti.
According to reports, gadoterol injection is the third approved product of Kelun Pharmaceutical in the field of diagnostic imaging after iopamidol injection and disodium gadoxetate injecti.
The declared gadobutrol injection and the series of X-ray, magnetic resonance and ultrasound contrast agents under development together form a cluster of advantageous products in the field of diagnostic contra.
It is worth mentioning that in recent years, Kelun Pharmaceutical has achieved a lot in terms of first generic drugs through innovati.
On April 29 this year, Kelun Pharmaceuticals issued an announcement that Sildenafil Citrate Orally Disintegrating Tablets was approved, which is also the first imitation in Chi.
According to the data, sildenafil is the first phosphodiesterase type 5 selective inhibitor approved in the world for the treatment of erectile dysfuncti.
first-line medicati.
In 2020, China's public hospitals and retail pharmacies sold a total of 66 billion yu.
Hengrui Medicine Diquafosol Sodium Eye Drops Approved for Marketing On May 27, NMPA issued an approval document showing that Hengrui Medicine's "Diquafosol Sodium Eye Drops" was approved for marketing, which is deemed to have passed the consistency evaluation and became the The first imitation in Chi.
Diquafosol sodium is a P2Y2 receptor agonist, which acts on P2Y2 receptors on the conjunctival epithelium and goblet cell membrane, and improves dry eye disease by up-regulating intracellular calcium ion concentration and promoting the secretion of water and muc.
sympto.
The drug was developed by Santen Pharmaceutical under license from Inspire Pharmaceuticals (a subsidiary of Merck) and was approved in Japan for the treatment of dry eye in October 201 It was approved for import in China in October 2017, and the trade name is Liai.
At present, in addition to Hengrui, five other companies have also applied for diquafosol sodium eye drops, including Qilu Pharmaceutical, Yangzijiang Pharmaceutical, and Xingqi Eye Dro.
It is understood that since the beginning of this year, Hengrui Medicine has approved a number of first generic drugs for marketi.
For example, on January 20, the three types of generic drug "Nimodipine Oral Solution" submitted by Hengrui Medicine were approved for marketi.
At present, the approved dosage forms of nimodipine in China include ordinary tablets, capsules, and injectio.
This time, Hengrui Medicine's nimodipine oral solution has been reviewed and won the first domestic imitation + first review of this varie.
Conclusion In fact, the first generic drugs have always been one of the focuses of domestic pharmaceutical companies' R&D layout, especially with the continuous advancement of the drug review reform, such drugs are becoming a sharp weapon for market competiti.
The industry expects that more and more generic drugs will be launched in the future, and with the approval of more generic drugs and new drugs under research, the competition in the domestic pharmaceutical market will become more intense, and the pace of domestic substitution will also be further speed .
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.
